CLINICAL TRIALS PROFILE FOR MENOSTAR
✉ Email this page to a colleague
All Clinical Trials for MENOSTAR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00185237 ↗ | Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch | Completed | Bayer | Phase 3 | 2005-07-01 | 150 postmenopausal Asian women with vasomotor symptoms, after fulfilling the inclusion and exclusion criteria will be enrolled in the study. The women will be randomly assigned to one of two treatment groups (Menostar® or placebo), after which they will be asked to use a patch once a week for 12 weeks. |
NCT00310531 ↗ | 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women | Completed | Bayer | Phase 3 | 2004-02-01 | The aim of this trial is to investigate whether the Menostar patch is as safe and effective in the prevention of bone loss in postmenopausal women as raloxifen, a drug already registered for prevention and treatment of osteoporosis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MENOSTAR
Condition Name
Clinical Trial Progress for MENOSTAR
Clinical Trial Phase
Clinical Trial Sponsors for MENOSTAR
Sponsor Name